ArriVent BioPharma Inc. Common Stock (AVBP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ArriVent BioPharma Inc. C...

    NASDAQ: AVBP · Real-Time Price · USD
    19.84
    1.01 (5.36%)
    At close: Oct 03, 2025, 3:59 PM
    19.84
    0.00%
    After-hours: Oct 03, 2025, 04:04 PM EDT

    ArriVent BioPharma Common Stock Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 74.29M 150.39M 163.37M 37.28M
    Short-Term Investments
    		 144.57M n/a n/a n/a
    Long-Term Investments
    		 47.68M n/a n/a 2K
    Other Long-Term Assets
    		 126K 2.84M 72K 87K
    Receivables
    		 500K 761K 500K 250K
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 n/a 8.69M n/a n/a
    Total Current Assets
    		 226.98M 159.97M 182.62M 42.95M
    Property-Plant & Equipment
    		 154K 291K 139K n/a
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 47.96M 3.13M 211K 89K
    Total Assets
    		 274.94M 163.1M 182.83M 43.04M
    Account Payables
    		 3.78M 4.53M 3.09M 293K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 162K n/a n/a n/a
    Other Current Liabilities
    		 -162K 3.6M 2.46M n/a
    Total Current Liabilities
    		 17.27M 11.62M 8.36M 1.82M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 14K 177K 11K n/a
    Total Liabilities
    		 17.29M 11.8M 8.37M 1.82M
    Total Debt
    		 176K 317K 139K n/a
    Book Value
    		 257.65M 151.3M 174.46M 41.22M
    Book Value Per Share
    		 8.19 4.73 5.21 32.31
    Common Stock
    		 3K n/a 4K 4K
    Retained Earnings
    		 -238.33M -157.84M -88.51M -51.61M
    Comprehensive Income
    		 -211K n/a -4K -4K
    Shareholders Equity
    		 257.65M 151.3M 174.46M 41.22M
    Total Investments
    		 192.25M n/a n/a 2K

    Add to Watchlist